Immunovant Inc (IMVT) — Financial Flexibility Index
Immunovant Inc (IMVT) has a Financial Flexibility Index of -1.39x as of December 2025. Free cash flow of $-92.33 Million (operating CF $-92.33 Million minus capex $0.00) represents -1% of total liabilities ($66.26 Million). Check Immunovant Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunovant Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Immunovant Inc across 8 annual periods. See Immunovant Inc (IMVT) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immunovant Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Immunovant Inc. For the full company profile including market capitalisation, see Immunovant Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.45x | $-375.12 Million | $-375.87 Million | $68.78 Million | ▼ -24.8% |
| 2024 | -4.37x | $-213.87 Million | $-214.23 Million | $48.95 Million | ▼ -0.7% |
| 2023 | -4.34x | $-188.00 Million | $-188.19 Million | $43.34 Million | ▼ -87.4% |
| 2022 | -2.31x | $-105.86 Million | $-106.11 Million | $45.74 Million | ▲ +41.5% |
| 2021 | -3.96x | $-83.12 Million | $-83.33 Million | $21.01 Million | ▼ -13.6% |
| 2020 | -3.48x | $-53.33 Million | $-53.36 Million | $15.32 Million | ▲ +95.4% |
| 2019 | -74.90x | $-28.50 Million | $-28.55 Million | $380.45K | ▲ +6.0% |
| 2018 | -79.66x | $-128.25 Million | $-128.30 Million | $1.61 Million | — |